X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-04 | BMY | Holzer Phil M | SVP, Controller | S - Sale | $55.62 | -700 | 11,760 | -6% | -$38,931 | ||||||
2024-11-01 | BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | P - Purchase | $54.68 | +1,830 | 62,109 | +3% | +$100,055 | ||||||
2023-12-05 | BMY | Boerner Christopher S. | CEO | P - Purchase | $49.78 | +2,000 | 82,672 | +2% | +$99,560 | ||||||
2023-11-28 | BMY | Boerner Christopher S. | CEO | P - Purchase | $48.86 | +3,071 | 79,384 | +4% | +$150,049 | ||||||
2023-11-20 | BMY | Samuels Theodore R. II | Dir | P - Purchase | $49.81 | +8,500 | 35,500 | +31% | +$423,385 | ||||||
2023-08-24 | BMY | Powell Ann | EVP, Chief HR | S - Sale | $61.25 | -17,986 | 27,868 | -39% | -$1,101,643 | ||||||
2023-08-03 | BMY | Plenge Robert M | EVP, Chief Research Officer | S - Sale | $61.14 | -732 | 6,784 | -10% | -$44,754 | ||||||
2023-05-03 | BMY | Vessey Rupert | EVP, Pres, Research | S - Sale | $67.06 | -50,385 | 48,407 | -51% | -$3,378,818 | ||||||
2023-02-06 | BMY | Caforio Giovanni | Board Chair, CEO | S - Sale | $74.65 | -240,000 | 236,104 | -50% | -$17,916,000 | ||||||
2023-02-06 | BMY | Powell Ann | EVP, Chief HR | S - Sale | $74.69 | -11,183 | 23,043 | -33% | -$835,258 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |